Table 2.
Preoperative demographic and clinical data of the two study groups of patients who underwent total hip arthroplasty
| Variables | Control Group | ACERTO Group | pa | ||
|---|---|---|---|---|---|
| (n = 17): | (n = 15) | ||||
| n(%) or Mean ± DP | n(%) or Mean ± DP | ||||
| Age (years) | 58 | ±17 | 57 | ±12 | 0.92 |
| Sex | |||||
| Male | 8 | 47 % | 8 | 53 % | 0.72 |
| Female | 9 | 53 % | 7 | 47 % | |
| Comorbiditiesb | |||||
| Yes | 10 | 59 % | 12 | 80 % | 0.20 |
| No | 7 | 41 % | 3 | 20 % | |
| Nutritional | |||||
| Assessment | |||||
| Malnourished | 5 | 29 % | 2 | 13 % | 0.40 |
| Eutrophic | 12 | 71 % | 13 | 87 % | |
| Immune supplement | |||||
| Yes | 0 | 0 % | 15 | 87 % | <0.01 |
| No | 17 | 100 % | 0 | 13 % | |
| Fasting time (h) | 9.52 | ±1.54 | 2 | ±0 | <0.001 |
| Hb (g/dL) | 13.35 | ±1.10 | 12.95 | ±1.39 | 0.38 |
| CRP (g/L) | 10.24 | ±5.09 | 10.13 | ±6.38 | 0.96 |
SD standard deviation; n number of patients; VHS velocity of hemo- sedimentation; CRP C-reactive protein; Hb hemoglobin
aChi square, Fisher Exact Test and Wilcoxon t test
bDiabetes mellitus, arterial hypertension, or chronic obstructive pulmonary disease